Clinical Trials
3 trialsNCT03817125 2024-06-06
MCGRAW
Parker Institute for Cancer Immunotherapy
Phase 1 Completed
NCT01967758 2018-08-17
Phase I Study of Safety and Immunogenicity of ADU-623
Providence Health & Services
Phase 1 Completed
NCT01042704 2017-07-31
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
University of Pittsburgh
Phase 1 Completed